|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 22, 2016 ) Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.
Publisher's analysts forecast the global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-liver-cirrhosis-market-2016-2020 .
The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001236138/buying .
Key vendors
- F Hoffman La-Roche
- GlaxoSmithKline
- Gilead Sciences
- Johnson & Johnson
- Merck
Other prominent vendors
- Bristol-Myers Squibb
- Conatus Pharmaceuticals
- Gwo Xi Stem Cell Applied Technology
- Instituto Grifols
- Intercept Pharmaceuticals
- NGM Biopharmaceuticals
- Norgine
- Pharmicell
- Salix Pharmaceuticals
- Stempeutics Research
Market driver
- High prevalence of liver cirrhosis
- For a full, detailed list, view our report
Market challenge
- Adverse effects of drugs
- For a full, detailed list, view our report
Market trend
- Use of off-label drugs
- For a full, detailed list, view our report
Buy this Report: http://www.reportsweb.com/buy&RW0001236138/buy/2500 .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
